Rabies immune globulin, human Withdrawn Phase 4 Trials for Virus Diseases Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03192371A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children